StockData

VitaNova Life Sciences Corp (VNOV) stock

VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026Market cap $37.52MP/E –Yield –

VitaNova Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

VitaNova Life Sciences's operating cash flow for the twelve months ending Jul 31, 2026 was $557.56K, down 42.0% year over year. For fiscal 2026 it was $814.41K, up 322.5% from the year before. The highest annual figure on record is $814.41K in fiscal 2026.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Apr 30, 2026$814.41K+322.5%
FY2025Apr 30, 2025$192.77K–
FY2024Apr 30, 2024-$375.88K–
FY2023Apr 30, 2023-$18.38K-552.5%
FY2022Apr 30, 2022$4.06K–
FY2021Apr 30, 2021-$42.29K–
FY2020Apr 30, 2020-$53.58K–
FY2019Apr 30, 2019-$49.11K–
FY2017Jan 25, 2017-$6.49K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$6.97K-97.4%
Q4 FY2026CQ1 2026Apr 30, 2026$428.31K-10.6%
Q3 FY2026CQ4 2025Jan 31, 2026-$90.38K-143.3%
Q2 FY2026CQ3 2025Oct 31, 2025$212.66K+2327.6%
Q1 FY2026CQ2 2025Jul 31, 2025$263.81K–
Q4 FY2025CQ1 2025Apr 30, 2025$479.14K–
Q3 FY2025CQ4 2024Jan 31, 2025$208.88K–
Q2 FY2025CQ3 2024Oct 31, 2024$8.76K–
Q1 FY2025CQ2 2024Jul 31, 2024-$504.00K–
Q4 FY2024CQ1 2024Apr 30, 2024-$191.19K–
Q3 FY2024CQ4 2023Jan 31, 2024-$150.56K–
Q2 FY2024CQ3 2023Oct 31, 2023-$7.99K-250.6%
Q1 FY2024CQ2 2023Jul 31, 2023-$26.15K-485.6%
Q4 FY2023CQ1 2023Apr 30, 2023-$2.29K–
Q3 FY2023CQ4 2022Jan 31, 2023-$28.18K-637.5%
Q2 FY2023CQ3 2022Oct 31, 2022$5.31K-72.9%
Q1 FY2023CQ2 2022Jul 31, 2022$6.78K–
Q4 FY2022CQ1 2022Apr 30, 2022-$13.83K–
Q3 FY2022CQ4 2021Jan 31, 2022$5.24K–
Q2 FY2022CQ3 2021Oct 31, 2021$19.59K–
Q1 FY2022CQ2 2021Jul 31, 2021-$6.94K–
Q4 FY2021CQ1 2021Apr 30, 2021$0–
Q3 FY2021CQ4 2020Jan 31, 2021-$11.72K–
Q2 FY2021CQ3 2020Oct 31, 2020-$30.57K–
Q1 FY2021CQ2 2020Jul 31, 2020$0–
Q4 FY2020CQ1 2020Apr 30, 2020-$14.80K–
Q3 FY2020CQ4 2019Jan 31, 2020-$7.22K–
Q2 FY2020CQ3 2019Oct 31, 2019-$11.68K–
Q1 FY2020CQ2 2019Jul 31, 2019-$19.88K–
Q4 FY2019CQ1 2019Apr 30, 2019-$13.65K–
Q1 FY2019CQ2 2018Jul 31, 2018-$10.82K–

More VitaNova Life Sciences figures

See a number that looks wrong?